Expert Review of Neurotherapeutics

Article	Citations
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	42
The latest developments with internet-based psychological treatments for depression	39
Steps to manage treatment-refractory migraine in adults	39
Where Art Thou O treatment for diabetic neuropathy: the sequel	36
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	33
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	31
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	29
The relevance of cortical thickness in migraine sufferers and implications to therapy	27
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms	27
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	26
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options	25
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	25
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 2025	23
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	22
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents	22
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	22
Advances in the treatment and management of frontotemporal dementia	22
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis	22
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia	22
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	21
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead	21
Why is ADHD so difficult to diagnose in older adults?	21
Hesitancies in primary headaches treatments	20
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder	20
Correction	19

Spinal automaticity of movement control and its role in recovering function after spinal injury	19
Electroconvulsive therapy in patients with trauma and personality disorders: what is the evidence?	19
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor	19
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan	18
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature	18
Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?	18
Mindfulness as a therapeutic option for obsessive-compulsive disorder	17
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations	17
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension	17
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms	17
The differential diagnosis of autism spectrum disorder in adults	16
Multimodal approaches to the treatment of personality disorder	16
Virtual reality technology in the treatment of anxiety – progress and future challenges	16
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients	16
Advances in the early diagnosis of amyotrophic lateral sclerosis	16
Current use of neurotoxins for alleviating symptoms of cervical dystonia	16
Considerations for hormonal therapy in migraine patients: a critical review of current practice	15
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound	15
The impact of sleep apnea on epilepsy treatment outcomes	15
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy	15
Diagnostic advances and challenges in meningioma	15
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review	14
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools	14
Advances in gene therapy for high-grade glioma: a review of the clinical evidence	14
A novel treatment option for intrajejunal levodopa administration	13
Persistent post-concussion syndrome: pathophysiology, diagnosis, current and evolving treatment strategies	13
Illuminating the way: the role of bright light therapy in the treatment of depression	13
Considering hearing loss as a modifiable risk factor for dementia	12
Frontotemporal dementia. How to deal with its diagnostic complexity?	12
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France	12
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	12
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective	12
Cross-national reflections on medicinal cannabis and depression	12
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes	12
Advancements in neuroactive peptides in seizures	12
Long-term outcomes in refractory status epilepticus	12
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)	12
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature	12
Pathogenesis of comorbid epilepsy in Alzheimer’s disease and use of perampanel, an AMPA receptor inhibitor	12
Updated review of rescue treatments for seizure clusters and prolonged seizures	11
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability	11
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?	11
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease	11
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?	11
Advances in the diagnosis of pediatric arterial ischemic stroke – imaging and beyond	11
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis	10
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?	10
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions	10
Could self-reporting sleep duration become an important tool in the prediction of dementia?	10
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression	10

Bipolar disorder staging and the impact it has on its management: an update	10
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes	10
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	10
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence	10
Meniere disease subtyping: the direction of diagnosis and treatment in the future	9
Stem cell therapy for patients with paraplegia: is there hope for the future?	9
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review	9
Developments in targeting calcitonin gene-related peptide	9
The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome	9
Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?	9
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions	9
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions	9
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review	9
Therapeutic issues in Guillain–Barré syndrome	9
Long-term central nervous system (CNS) consequences of COVID-19 in children	9
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain	9
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	9
Rethinking the role of trazodone in the different depressive dimensions	9
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions	9
Contemporary perspectives in cerebral amyloid angiopathy	8
Important context missing from “contemporary perspectives in cerebral amyloid angiopathy”	8
Deep brain stimulation: new programming algorithms and teleprogramming	8
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review	8
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis	8
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations	8
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?	8
Suicide and suicidal behaviors: insight into clinical challenges and preventive measures	8
The major challenges with pharmacologic management of chronic traumatic encephalopathy	8
Tobacco use disorder and depression: emerging strategies and recommendations:	8
Risk of suicide and suicide-related events in subjects treated with antiseizure medications	8
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	8
Learnings in developmental and epileptic encephalopathies: what do we know?	8
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease	8
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis	8
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis	8
The challenges and opportunities related to the therapeutic use of music in psychiatry	7
Superior treatment efficacy of neuromodulation rehabilitation for upper limb recovery after stroke: a meta-analysis	7
Adaptive, personalized closed-loop therapy for Parkinson’s disease: biochemical, neurophysiological, and wearable sensing systems	7
Letter to the editor: reflections on the future of medical cannabis research for depression	7
Contemporary diagnosis and treatment of conduct disorder in youth	7
An update on pharmacotherapy for trigeminal neuralgia	7
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?	7
Pharmacological approaches to the management of panic disorder in older patients: a systematic review	7
The value of radiotherapy in patients with recurrent atypical meningioma: an update	7
A critical review of fosphenytoin sodium injection for the treatment of status epilepticus in adults and children	7
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment	7
The complexities in the differential diagnosis of restless legs syndrome (Willis–Ekbom disease)	7
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments	7
A proposal for a shared therapeutic algorithm in children with prolonged convulsive seizures and status epilepticus	7
Re-evaluating the prognosis of schizophrenia: tackling the issue of inadequate treatment	7
What impact can brain stimulation interventions have on borderline personality disorder?	6
Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients	6
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis	6
Current and emerging therapies for autoimmune encephalitis	6
The burden of migraine in Mexico: a database analysis of migraine-related visits to emergency departments in Mexico’s Ministry of Health (MMoH) hospitals	6
Considerations for the treatment of obsessive-compulsive disorder in patients who have comorbid major depression	6
Neuromodulation as a therapeutic approach for post-traumatic stress disorder: the evidence to date	6
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes	6
The latest views on how vagus nerve stimulation works in epilepsy: a plain language summary	6
Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review	6
The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines	6
Expert guidance on the differential diagnosis of neuroleptic malignant syndrome	6
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation	6
When is pharmacological intervention recommended for adults with social anxiety disorder?	6
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead	6
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent	6
Is it possible to prevent relapse in panic disorder?	6
Updated perspectives on how and when lithium should be used in the treatment of mood disorders	6
Obtaining long-term recovery: advances in optimizing treatment outcomes in patients with binge-eating disorder	6
Advances in stem cell-based therapeutic transfers for glioblastoma treatment	6
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders	6
Mobile health technologies for the management of Parkinson’s disease	6
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial	6
Central vestibular dysfunction: don’t forget vestibular rehabilitation	6
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development	6
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	6
Correlation between systemic bleeding during thrombolysis and intracranial hemorrhage after thrombolysis in acute ischemic stroke	5
Imaging of congenital and developmental cystic lesions of the brain: a narrative review	5
Pharmacological options for narcolepsy: are they the way forward?	5
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder?	5

The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder	5
New trends in the treatment of blepharospasm: replacing the standardized approach with a personalized approach	5
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience	5
Therapeutic barriers for headache management: issues facing the global north and global south in 2024	5
Insights into headache 2022	5
Assessing cognitive impairment among pediatric epilepsies: a systematic review	5
Effectiveness of virtual reality rehabilitation with exergames on functional rehabilitation in Parkinson’s disease: a systematic review of chronic randomized controlled trials	5
A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder	5
An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents	5
How does “Pure-O” obsessive-compulsive disorder impact on a patient’s treatment plan?	5
Paroxysmal sympathetic hyperactivity (PSH) after traumatic brain injury: the pathophysiological role of glutamate and potential treatment with branched-chain amino acids	5
Challenges in the treatment of dysthymia: a narrative review	5
Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?	5
The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?	5
Rethinking the medication management of major depression	5
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	5
Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses	4
Acute and prophylactic treatment of dialysis headache: a systematic review	4
Are ketamine and its enantiomers the answer to treatment-refractory depression?	4
Risk factors and disease associations in people living with idiopathic intracranial hypertension	4
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	4
The impact of cognitive reserve relative to risk of Alzheimer’s disease and rate of progression: an up-to-date review of the literature	4
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry	4
Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence	4
Can regular physical exercise be a treatment for panic disorder? A systematic review	4
Trichotillomania and its treatment: an updated review and recommendations	4
The utility of magnetoencephalography in epilepsy and its implications for treatment	4
Withdrawal of antiseizure medications – for whom, when, and how?	4
Evaluating clazosentan sodium for the treatment of aneurysmal subarachnoid hemorrhage	4
Emerging frontiers in Chronic Traumatic Encephalopathy: early diagnosis and implications for neurotherapeutic interventions	4
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?	4
Brain atrophy assessment in multiple sclerosis: technical– and subject-related barriers for translation to real-world application in individual subjects	4
What is the role of placebo in neurotherapeutics?	4
Current perspectives on the diagnosis and management of acute transverse myelitis	4
UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder	4
Adapting psychedelic medicine for headache and chronic pain disorders	4
Therapeutic strategies that modulate the acute phase of secondary spinal cord injury scarring and inflammation and improve injury outcomes	4
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome	4
How could brain fingerprinting lead to the early detection of mental illness in adolescents and what are the next steps?	4
Accelerating the development of noninvasive brain stimulation devices: using design thinking to facilitate its clinical use and acceptance	4
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond	4
Can pharmacotherapy help to reduce trichotillomania?	3
Essential tremor - drug treatments present and future	3
Nanomaterials in neuromodulation: what is the potential?	3
Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials	3
Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints	3
Unlocking the potential of virtual reality for post-stroke sensorimotor rehabilitation - are we any closer?	3
Managing cognitive impairment in Parkinson’s disease: an update of the literature	3
Advances in the treatment of familial dysautonomia: what does the future hold?	3
Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications	3
Status epilepticus in pregnancy: a literature review and a protocol proposal	3
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease	3
An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke	3
Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers	3
The management of neurofibromatosis type 1 (NF1) in children and adolescents	3
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis	3
Preventing recurrence of postpartum depression by regulating sleep	3
Personal narratives and the pursuit of purpose and possibility in psychosis: directions for developing recovery-oriented treatments	3
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias	3
Overcoming clinical challenges of refractory neuropathic pain	3
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection	3
Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome	3
Zonisamide oral suspension as adjunctive therapy for treating partial seizures in adults and in pediatric patients aged 16 years and older with epilepsy	3
Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia	3
Current and emerging treatment options for Angelman syndrome	3
Careful considerations for the treatment of posttraumatic stress disorder during and following pregnancy	3
Pharmacological interventions to improve sleep in people with Alzheimer’s disease: a meta-analysis of randomized controlled trials	3
An evaluation of onobotulinumtoxinA as a therapeutic option for pediatric neurogenic detrusor overactivity	3
Updated strategies for the management of poor medication adherence in patients with bipolar disorder	3
Exploring the natural age cutoff point for primary-progressive multiple sclerosis therapy	3
Impact of psychiatric comorbidities on the treatment of epilepsies in adults	3
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder	3
Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome	3
Current perspectives on the clinical management of cryptogenic stroke	3
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	3
Redefining insomnia: from neural dysregulation to personalized therapeutics	3
Real world considerations for newly approved CGRP receptor antagonists in migraine care	3